Pharmacovigilance Assessment of Immune-Mediated Reactions Reported for Checkpoint Inhibitor Cancer Immunotherapies. [electronic resource]
Producer: 20180621Description: 1383-1390 p. digitalISSN:- 1875-9114
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Bayes Theorem
- Female
- Humans
- Immunotherapy -- adverse effects
- Ipilimumab -- administration & dosage
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Nivolumab
- Pharmacovigilance
- Retrospective Studies
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.